EmboMedics Receives Patent from USPTO

The Unites States Patent Office has granted EmboMedics full patent

Online PR News – 12-January-2014 – December 31st, Minneapolis/MN – EmboMedics and The University of MN have been notified of the issuace of a worldwide patent on resorbable embolization technology."This is great news indeed" said Omid Souresrafil, the CEO of EmboMedics. With the closing of our series A funding this gives us the exact tools necessary to seek approval of our devices and build our patent portfolio in the resorbable areana.

Contact Information
Omid Souresrafil
17127 80th Place North
Maple Grove MN, 55311